SMTL ID : 5v24.2 (1 other biounit)

Structure-based drug design of novel ASK1 inhibitors using a fully integrated lead optimization strategy

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

monomer

Ligands

1 x 8V7: 2-[4-(propan-2-yl)-4H-1,2,4-triazol-3-yl]-N-(pyridin-2-yl)-1,3-thiazole-4-carboxamide(Non-covalent)

8V7.1: 16 residues within 4Å: Chain A: L.17, G.18, K.19, G.20, V.25, A.38, K.40, M.85, E.86, Q.87, V.88, G.91, D.138, L.141, S.152, D.153 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:V.25 Hydrogen bonds: A:V.88, A:D.153

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gibson, T.S. et al., Structure-based drug design of novel ASK1 inhibitors using an integrated lead optimization strategy. Bioorg. Med. Chem. Lett. (2017)

Release Date

2017-03-29

Peptides

Mitogen-activated protein kinase kinase kinase 5: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Mitogen-activated protein kinase kinase kinase 5

Related Entries With Identical Sequence